Price Chart

Profile

Gain Therapeutics Inc is a biotechnology company developing novel small molecule therapeutics to treat diseases across, several therapeutics areas, including, lysosomal storage disorders, central nervous system disorders, metabolic disorders and oncology. The company has filed four patent applications for novel small molecule drug candidates that are Structurally Targeted Allosteric Regulators (STARs). The company derives revenues from collaboration and licensing agreements.
URL https://www.gaintherapeutics.com
Investor Relations URL N/A
HQ State/Province Maryland
Sector Healthcare
Industry Biotechnology
Equity Style Small Cap/Value
Next Earnings Release Mar. 22, 2024 (est.)
Last Earnings Release Nov. 14, 2023
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Profile

Gain Therapeutics Inc is a biotechnology company developing novel small molecule therapeutics to treat diseases across, several therapeutics areas, including, lysosomal storage disorders, central nervous system disorders, metabolic disorders and oncology. The company has filed four patent applications for novel small molecule drug candidates that are Structurally Targeted Allosteric Regulators (STARs). The company derives revenues from collaboration and licensing agreements.
URL https://www.gaintherapeutics.com
Investor Relations URL N/A
HQ State/Province Maryland
Sector Healthcare
Industry Biotechnology
Equity Style Small Cap/Value
Next Earnings Release Mar. 22, 2024 (est.)
Last Earnings Release Nov. 14, 2023
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A